Pneumococcal Conjugate (PCV) Vaccine for children and risk groups 2025-2026 and (2026-2027, 2027-2028)

roups belonging to the National Vaccination Programme in Finland. The contract period is two years 2025 - 2026. The procurement contains two contract period renewals (1+1) to extend the contract for the periods 2026 - 2027 and 2027-2028. The procurement contains additional procurement option for max

imum 50.000 doses but it does not create any obligation by the Customer to purchase any additional vaccine doses from Supplier. THL will supply a written notification for contract period renewals and additional procurement option with the f